Science policy weekly roundup: April 26, 2019 ?>

Science policy weekly roundup: April 26, 2019

Apply for the ASBMB Advocacy Training Program today

Are you curious about getting involved in science advocacy? Do you want to make a difference in your community? Are you thinking of science policy as a possible career path? Apply to the ASBMB Advocacy Training Program today. The ASBMB ATP is a six-month externship that provides hands-on science policy and advocacy training and experience. You will spend the first two months learning about science policy and advocacy and about how federal laws and budgets are passed. With support from ASBMB public affairs staff, you will develop and carry out advocacy activities focused on policies facing your local community. We are accepting applications until 5 p.m. Eastern on Monday, May 20.  Apply today. 

Texas research institution removes three scientists over fear of foreign influence and espionage

Officials from University of Texas MD Anderson Cancer Center removed three scientists for sharing confidential information with Chinese institutions and failure to disclose payment and collaborations with foreign entities. MD Anderson is one of 55 institutions contacted by the National Institutes of Health regarding concerns about foreign influence by scientists working in these labs. Read more here.  

First U.S. human clinical trials involving CRISPR begins

A clinical trial using CRISPR technology to treat human cancer patients began this week, a first in a several clinical trials that will utilize the gene-editing technology in human patients. U.S. scientists are proceeding with caution in the wake of a controversial study that used CRISPR to edit genes of human embryos. Questions about CRISPR’s safety and reliability, especially when used in humans, remain. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.